SCHEMBL1332157

SCHEMBL1332157

NC(=O)c1nc2ccccc2c(O)c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K3 P46734 2/20 0.50
LCK P06239 1/20 0.50
MAP2K6 P52564 1/20 0.50
BTK Q06187 1/20 0.50
MAP3K19 Q56UN5 1/20 0.50
NEK10 Q6ZWH5 1/20 0.50
ALDH1A1 P00352 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
MAPT P10636 1/20 0.48
DYRK1A Q13627 2/20 0.44
DHODH Q02127 2/20 0.44
PDE10A Q9Y233 1/20 0.44
GRM2 Q14416 4/20 0.43
NCOA1 Q15788 1/20 0.43
NCOA3 Q9Y6Q9 1/20 0.43
KDM4A O75164 1/20 0.42
KDM5B Q9UGL1 1/20 0.42
ELANE P08246 1/20 0.41
ADORA3 P0DMS8 2/20 0.41
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29849579 0.85 ALDH1A1 (0.63) ALDH1A1SMN1; SMN2MAPTDYRK1ADHODH
SCHEMBL296952 0.85 ALDH1A1 (0.63) ALDH1A1SMN1; SMN2MAPTDYRK1ADHODH
SCHEMBL7673424 0.84 LCK (0.46) MAP2K3LCKMAP2K6BTKMAP3K19
SCHEMBL28279288 0.81 MAP2K3 (0.53) MAP2K3LCKMAP2K6BTKMAP3K19
SCHEMBL752001 0.81 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2MAPTDHODHPDE10A
SCHEMBL1332816 0.80 POLB (0.50) MAP2K3LCKMAP2K6BTKMAP3K19
SCHEMBL6079236 0.79 HDAC8 (0.48) ALDH1A1SMN1; SMN2MAPTDHODHPDE10A
SCHEMBL6890781 0.78 LCK (0.69) MAP2K3LCKMAP2K6BTKMAP3K19
SCHEMBL30713425 0.76 DHODH (0.46) MAP2K3LCKMAP2K6BTKMAP3K19
SCHEMBL28149300 0.76 ALDH1A1 (0.57) MAP2K3LCKMAP2K6BTKMAP3K19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11712425-B2 Immunoregulatory role of 3-OH-kynurenamine and uses thereof ALBERT EINSTEIN COLLEGE OF MEDICINE (US) 2023-08-01 US claimed
CN-114624343-B Method for relatively quantifying 45 inflammations and immune metabolites in serum 中国科学院大连化学物理研究所 2023-01-24 CN claimed
CN-114624343-A Method for relative quantification of 45 inflammations and immune metabolites in serum 中国科学院大连化学物理研究所 2022-06-14 CN claimed
US-20210008021-A1 IMMUNOREGULATORY ROLE OF 3-OH-KYNURENAMINE AND USES THEREOF ALBERT EINSTEIN COLLEGE OF MEDICINE 2021-01-14 US claimed
WO-2019178013-A1 IMMUNOREGULATORY ROLE OF 3-OH-KYNURENAMINE AND USES THEREOF ALBERT EINSTEIN COLLEGE OF MEDICINE (US) 2019-09-19 WO claimed
US-11712425-B2 Immunoregulatory role of 3-OH-kynurenamine and uses thereof ALBERT EINSTEIN COLLEGE OF MEDICINE (US) 2023-08-01 US disclosed
US-11712425-B2 Immunoregulatory role of 3-OH-kynurenamine and uses thereof ALBERT EINSTEIN COLLEGE OF MEDICINE (US) 2023-08-01 US disclosed
US-11712425-B2 Immunoregulatory role of 3-OH-kynurenamine and uses thereof ALBERT EINSTEIN COLLEGE OF MEDICINE (US) 2023-08-01 US disclosed
CN-114624343-B Method for relatively quantifying 45 inflammations and immune metabolites in serum 中国科学院大连化学物理研究所 2023-01-24 CN disclosed
CN-114624343-A Method for relative quantification of 45 inflammations and immune metabolites in serum 中国科学院大连化学物理研究所 2022-06-14 CN disclosed
US-20210008021-A1 IMMUNOREGULATORY ROLE OF 3-OH-KYNURENAMINE AND USES THEREOF ALBERT EINSTEIN COLLEGE OF MEDICINE 2021-01-14 US disclosed
US-20210008021-A1 IMMUNOREGULATORY ROLE OF 3-OH-KYNURENAMINE AND USES THEREOF ALBERT EINSTEIN COLLEGE OF MEDICINE 2021-01-14 US disclosed
US-6210970-B1 Method of diagnosing or categorizing disorders from biochemical profiles ESA, INC. 2001-04-03 US disclosed
US-6194217-B1 CREATING DATABASE OF ELECTRICAL SIGNAL PATTERNS REPRESENTATIVE OF FREQUENCY DISTRIBUTION OF ELECTRICALLY ACTIVE CONSTITUENTS OF BIOLOGICAL SAMPLES FROM DIAGNOSED AND HEALTHY INDIVIDUALS, THEN COMPARING TEST SAMPLES TO DATABASE ESA, INC. 2001-02-27 US disclosed
EP-0567564-B1 Method for diagnosing disorders from biochemical profiles ESA INC (US) 1996-10-16 EP disclosed
EP-0567564-A1 METHOD OF DIAGNOSING OR CATEGORIZING DISORDERS FROM BIOCHEMICAL PROFILES. ESA INC (US) 1993-11-03 EP disclosed
EP-0201591-B1 METHOD FOR DEVELOPING PHARMACEUTICALS FOR TREATMENT OF DISORDERS ESA, Inc. (US) 1993-02-10 EP disclosed
WO-1992013273-A1 METHOD OF DIAGNOSING OR CATEGORIZING DISORDERS FROM BIOCHEMICAL PROFILES ESA, INC. (US) 1992-08-06 WO disclosed
US-5104639-A Analzing body fluid samples using electrochemical liquid chromatography, compraring measured concentration with other living organisms to identify differences in metabolic pathways and administering drugs to alter pathways ESA, INC. (US) 1992-04-14 US disclosed
US-4863873-A Method for biological testing and/or developing pharmaceuticals for treatment of disorders ESA, INC. (US) 1989-09-05 US disclosed